Position in EOLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$105,530
-$47,266 QoQ
Shares Held
25,677
+11.8% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $1,491,893,072 across 43 Drug Manufacturers - Specialty & Generic names. EOLS ranks #42 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
4,938,967 | $650,659,508 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
826,226 | $489,935,489 | |
| 3 | VTRS |
Viatris Inc
|
6,341,318 | $85,671,200 | |
| 4 | ZTS |
Zoetis Inc.
|
607,950 | $71,865,765 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
7,535,080 | $26,448,126 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
378,697 | $18,234,258 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
894,423 | $16,564,712 | |
| 8 | ALKS |
Alkermes plc.
|
383,977 | $13,577,424 |
All Filings in EOLS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $105,530 | 25,677 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $152,796 | 22,977 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $358,226 | 58,343 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $656,349 | 71,265 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $802,856 | 66,738 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $1,733,765 | 157,044 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,422,903 | 149,562 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $781,275 | 72,007 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $756,504 | 54,036 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $528,111 | 50,153 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $482,052 | 52,741 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $384,866 | 52,939 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $312,918 | 36,988 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $772,959 | 102,924 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $875,687 | 108,781 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $116,023 | 10,002 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $136,266 | 12,145 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $831,672 | 127,753 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $881,618 | 115,698 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,063,687 | 84,086 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||